primary progressive multiple sclerosis

Showing 1 - 25 of 32

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ocrelizumab on Cortical Lesion Accumulation in PPMS

Not yet recruiting
  • Primary Progressive Multiple Sclerosis
  • Ocrelizumab
  • (no location specified)
Aug 2, 2023

Ocrelizumab on Choroid Plexus Changes in Patients With PPMS

Not yet recruiting
  • Primary Progressive Multiple Sclerosis
  • Ocrelizumab
  • Buffalo, New York
    Buffalo Neuroimaging Analysis Center
Jul 26, 2023

Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary-progressive Multiple Sclerosis Trial in Belgium (Metformin

Not yet recruiting
  • Multiple Sclerosis
  • +2 more
  • Metformin Hydrochloride 850 mg Oral Tablet
  • Placebo
  • Brugge, Belgium
  • +4 more
May 30, 2023

Relapsing Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Worldwide (Ocrelizumab IV, Ocrelizumab SC,

Active, not recruiting
  • Relapsing Multiple Sclerosis
  • Primary Progressive Multiple Sclerosis
  • Ocrelizumab IV
  • +5 more
  • Tampa, Florida
  • +46 more
Jan 13, 2023

Upper Extremity Function in Multiple Sclerosis Advanced

Active, not recruiting
  • Multiple Sclerosis
  • +7 more
  • Tampa, Florida
    Carol and Frank Morsani Center for Advanced Healthcare
Nov 2, 2022

Primary Progressive Multiple Sclerosis Trial in Israel, Moldova, Republic of (GA Depot 40mg once monthly, GA Depot 25mg once

Recruiting
  • Primary Progressive Multiple Sclerosis
  • GA Depot 40mg once monthly
  • GA Depot 25mg once monthly
  • Haifa, Israel
  • +6 more
Oct 30, 2022

Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Australia, Canada, United States

Active, not recruiting
  • Primary Progressive Multiple Sclerosis
  • Secondary Progressive Multiple Sclerosis
  • ATA188
  • Placebo
  • La Jolla, California
  • +33 more
Jul 21, 2022

Primary Progressive Multiple Sclerosis, Exercise, Cardiorespiratory Fitness Trial in Valens (HIIT, MCT)

Recruiting
  • Primary Progressive Multiple Sclerosis
  • +2 more
  • HIIT
  • MCT
  • Valens, Sankt Gallen, Switzerland
    Klinik Valens, Valens rehabilitation clinic
Jun 9, 2022

Gray Matter Demyelination in Primary Progressive MS at 7T

Recruiting
  • Primary Progressive Multiple Sclerosis
    • Hvidovre, Denmark
      Danish Research Centre for Magnetic Resonance
    Jun 5, 2022

    Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Los Angeles (Metformin 500 Mg Oral

    Recruiting
    • Secondary Progressive Multiple Sclerosis
    • Primary Progressive Multiple Sclerosis
    • Metformin 500 Mg Oral Tablet, up to 4 tablets a day
    • Placebo oral tablet identical to metformin, up to 4 tablets a day
    • Los Angeles, California
      University of California, Los Angeles
    May 2, 2022

    Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial

    Recruiting
    • Relapsing Remitting Multiple Sclerosis
    • +2 more
    • Glostrup, Copenhagen, Denmark
    • +11 more
    May 3, 2022

    Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis Trial

    Active, not recruiting
    • Secondary Progressive Multiple Sclerosis
    • +2 more
    • Minneapolis, Minnesota
    • +2 more
    Mar 29, 2022

    Primary Progressive Multiple Sclerosis Trial in Worldwide (Placebo, Laquinimod)

    Completed
    • Primary Progressive Multiple Sclerosis
    • Phoenix, Arizona
    • +98 more
    Mar 9, 2022

    Relapsing Remitting Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial

    Recruiting
    • Relapsing Remitting Multiple Sclerosis
    • +2 more
    • Ixazomib (NINLARO®) capsules / Matching placebo capsules
    • London, Greater London, United Kingdom
      Royal London Hospital, Barts Health NHS Foundation Trust
    Feb 17, 2022

    Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Multiple Sclerosis Trial (Intranasal Foralumab

    Withdrawn
    • Primary Progressive Multiple Sclerosis
    • +2 more
    • Intranasal Foralumab Solution
    • Placebo
    • (no location specified)
    Feb 14, 2022

    Primary Progressive Multiple Sclerosis Trial in Durham (DUOC-01)

    Recruiting
    • Primary Progressive Multiple Sclerosis
    • DUOC-01
    • Durham, North Carolina
      Duke University Medical Center
    Jan 25, 2022

    Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Relapsing Multiple Sclerosis Trial in Boston

    Recruiting
    • Primary Progressive Multiple Sclerosis
    • +3 more
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jul 20, 2021

    Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Dublin (Fampridine, Placebo)

    Completed
    • Secondary Progressive Multiple Sclerosis
    • Primary Progressive Multiple Sclerosis
    • Dublin, Dublin 4, Ireland
    • +1 more
    Jul 8, 2021

    Primary Progressive Multiple Sclerosis the MURDOCK Study

    Completed
    • Primary Progressive Multiple Sclerosis
    • generation of 'omic markers of disease progression
    • Concord, North Carolina
    • +2 more
    May 26, 2021

    Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial run by the NIAID (Idebenone)

    Completed
    • Multiple Sclerosis
    • Primary Progressive Multiple Sclerosis
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Apr 27, 2021

    Primary Progressive Multiple Sclerosis Trial in Copenhagen (Dimethyl fumarate, Placebo)

    Completed
    • Primary Progressive Multiple Sclerosis
    • Dimethyl fumarate
    • Placebo
    • Copenhagen, Denmark
      Danish Multiple Sclerosis Center, Department of neurology
    Dec 22, 2020

    Multiple Sclerosis, Relapse, Primary Progressive Multiple Sclerosis Trial in Paris (Ocrelizumab)

    Recruiting
    • Multiple Sclerosis
    • +2 more
    • Paris, France
      Hôpital Saint-Antoine - Service de Neurologie
    Jan 27, 2020

    Primary Progressive Multiple Sclerosis, Hemiparesis Trial in Columbus (Gaming CI Therapy)

    Completed
    • Primary Progressive Multiple Sclerosis
    • Hemiparesis
    • Gaming CI Therapy
    • Columbus, Ohio
      The Ohio State University, 2154 Dodd Hall
    Apr 16, 2019

    Multiple Sclerosis, Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Portland (Alpha Lipoic

    Completed
    • Multiple Sclerosis
    • +3 more
    • Alpha Lipoic Acid
    • Portland, Oregon
      Oregon Health & Science University
    Mar 20, 2019

    Primary Progressive Multiple Sclerosis Trial run by the NIAID (Idebenone, )

    Completed
    • Primary Progressive Multiple Sclerosis
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Mar 6, 2019